The clinical effectiveness of Movicol in children with severe constipation: an outcome audit.
This audit reviewed the clinical effectiveness of polyethylene glycol 3350 plus electrolytes (PEG+E, Movicol) in the management of severe paediatric constipation. A seven-day disimpaction regimen was initiated followed by a maintenance dose as appropriate. An information and support service was provided by the community children's nursing team (CCNT) at Darent Valley Hospital. Twenty-three parents completed questionnaires on their children's experiences with previous and current laxative treatments, bowel movement status, in-patient admissions or home visits required and the perceived value of the back up service. The mean age of children studied was 6.7 years. Prior to PEG+E treatment, 57 per cent of children were admitted to hospital and 26 per cent required home visits for constipation treatment. After treatment, no child needed either intervention. Thirty-nine percent of parents used the support service, of which 96 per cent rated the information it provided as adequate. When asked about their satisfaction with the control of their children's constipation, 96 per cent of parents were 'more than happy' after treatment with PEG+E. The treatment of severe paediatric constipation with PEG+E in conjunction with a support and advice service was both clinically and economically effective.
Children's Resource Centre, Darent Valley Hospital, Kent.
Sandra
S
Hanson
Nav
N
Bansal
D000359:Aftercare / Q000458:organization & administration; D002648:Child; D003152:Community Health Nursing / Q000458:organization & administration; D003248:Constipation / Q000188:drug therapy* / Q000209:etiology / Q000451:nursing*; D004043:Dietary Fiber; D004327:Drinking Behavior; D006699:Home Care Services / Q000706:statistics & numerical data; D006801:Humans; D008019:Life Style; D008487:Medical History Taking; D009730:Nursing Assessment; D009731:Nursing Audit; D015403:Nursing Evaluation Research; D010290:Parents / Q000193:education; D010343:Patient Admission / Q000706:statistics & numerical data; D010371:Pediatric Nursing / Q000458:organization & administration; D011092:Polyethylene Glycols / Q000627:therapeutic use*; D015397:Program Evaluation; D012307:Risk Factors; D012720:Severity of Illness Index; D013501:Surface-Active Agents / Q000627:therapeutic use*; D011795:Surveys and Questionnaires; D016896:Treatment Outcome
D004043:Dietary Fiber; D013501:Surface-Active Agents; D011092:Polyethylene Glycols